Peptide Therapeutics Market is estimated to be US$ 66.18 billion by 2030 with a CAGR of 6.10% during

Ritvik12 Sep, 2022News

Peptide Therapeutics Market, By Type (Branded Peptide and Generic Peptide), By Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others), By Route of Administration (Oral Administration, Parenteral Administration and Others) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030